Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 3 |
2022 | 3 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
An intact complement system dampens cornea inflammation during acute primary HSV-1 infection.
Sci Rep. 2021 May 13;11(1):10247. doi: 10.1038/s41598-021-89818-9.
Sci Rep. 2021.
PMID: 33986436
Free PMC article.
Tripartite-Motif 21 (TRIM21) Deficiency Results in a Modest Loss of Herpes Simplex Virus (HSV)-1 Surveillance in the Trigeminal Ganglia Following Cornea Infection.
Berube A, Gmyrek GB, Royer DJ, Carr DJJ.
Berube A, et al.
Viruses. 2022 Mar 12;14(3):589. doi: 10.3390/v14030589.
Viruses. 2022.
PMID: 35336995
Free PMC article.
Item in Clipboard
HSV-1 0∆NLS vaccine elicits a robust B lymphocyte response and preserves vision without HSV-1 glycoprotein M or thymidine kinase recognition.
Gmyrek GB, Berube AN, Sjoelund VH, Carr DJJ.
Gmyrek GB, et al. Among authors: berube an.
Sci Rep. 2022 Sep 23;12(1):15920. doi: 10.1038/s41598-022-20180-0.
Sci Rep. 2022.
PMID: 36151255
Free PMC article.
Item in Clipboard
Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0ΔNLS vaccine against ocular HSV-1 challenge.
Carr DJJ, Berube AN, Filiberti A, Gmyrek GB.
Carr DJJ, et al. Among authors: berube an.
Vaccine. 2021 Apr 28;39(18):2526-2536. doi: 10.1016/j.vaccine.2021.03.075. Epub 2021 Apr 1.
Vaccine. 2021.
PMID: 33814229
Free PMC article.
Item in Clipboard
Osteopontin contributes to virus resistance associated with type I IFN expression, activation of downstream ifn-inducible effector genes, and CCR2+CD115+CD206+ macrophage infiltration following ocular HSV-1 infection of mice.
Filiberti A, Gmyrek GB, Berube AN, Carr DJJ.
Filiberti A, et al. Among authors: berube an.
Front Immunol. 2023 Jan 4;13:1028341. doi: 10.3389/fimmu.2022.1028341. eCollection 2022.
Front Immunol. 2023.
PMID: 36685562
Free PMC article.
Item in Clipboard
The Durability of Vaccine Efficacy against Ocular HSV-1 Infection Using ICP0 Mutants 0∆NLS and 0∆RING Is Lost over Time.
Carr DJJ, Berube A, Gershburg E.
Carr DJJ, et al. Among authors: berube a.
Pathogens. 2021 Nov 12;10(11):1470. doi: 10.3390/pathogens10111470.
Pathogens. 2021.
PMID: 34832625
Free PMC article.
Item in Clipboard
Distinguishing Features of High- and Low-Dose Vaccine against Ocular HSV-1 Infection Correlates with Recognition of Specific HSV-1-Encoded Proteins.
Carr DJJ, Gmyrek GB, Filiberti A, Berube AN, Browne WP, Gudgel BM, Sjoelund VH.
Carr DJJ, et al. Among authors: berube an.
Immunohorizons. 2020 Oct 9;4(10):608-626. doi: 10.4049/immunohorizons.2000060.
Immunohorizons. 2020.
PMID: 33037098
Free PMC article.
Item in Clipboard
Cite
Cite